🕵️ TURN Therapeutics Inc. ($TTRX)
SEC insider & ownership activity, last 12 months · CIK 2023016 · every row links its SEC filing
Over the last 12 months insiders bought $308K with no open-market selling against it. Arthur F. Golden bought $193K in discretionary trades (Oct–Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $308K (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Arthur F. Golden | 3 | $193K | 0 | – | Nov 24, 2025 |
| Chesed Abraham | 1 | $66K | 0 | – | Oct 23, 2025 |
| Chaudhary Zuraiz | 5 | $50K | 0 | – | Dec 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Bradley Burnam | 52.8% | 13G | Apr 6, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 18, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 23, 2026 | filing ↗ |
| New financial obligation (2.03) | Mar 23, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 7, 2026 | filing ↗ |